August 20, 2014
##EMAIL##, you've received this email because you're a
valued customer of IsoTech Design.

##EMAIL##, vous recevez ce courriel parce ce que vous êtes un précieux client d'IsoTech Design.
Home   About Us   News & Articles   Contact Us   Text Version   Subscribe   Unsubscribe
Accueil   À propos de nous   Nouvelles et Actualités   Contactez-nous   Version écrite   S'abonner   Se désabonner

Faster FDA approvals have not caused more drug safety problems
The media gave some attention to a new study, which suggested that the Food and Drug Administration (FDA) recklessly allows unsafe new prescription drugs onto the market. The research supports a longstanding suspicion that the Prescription Drug User Fee Act (PDUFA), first passed in 1992 and renewed every five years, has caused the FDA to view the research-based pharmaceutical industry as a “partner” and source of revenue, rather than a regulated industry.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

Compounding pharmacy industry launches member network
More benefits managers are moving to limit coverage of compounded pharmaceuticals, in part due to concerns about increasing costs and some instances of recalled compounded drugs. The industry is responding in a variety of ways to try to reassure skeptics that compounding should be viewed as part of the conventional therapeutic system. Now, a small group of compounding pharmacies has launched a network that, they say, will hold its members to the highest of standards and will work with benefits managers to allay their concerns.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

Vaccine safety signal from spontaneous system not supported by active surveillance
An FDA-funded study recently found that a safety signal detected from spontaneously submitted reports of vaccine-related adverse events did not hold up statistically when examined with an electronic active surveillance system.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

Pharmacists adopt prescription 'synching'
Brattleboro Reformer
Some people have multiple prescriptions, and keeping track of all them, when they need to be refilled and when they need to be taken, can be confusing and for some of those people, losing track of their prescriptions could endanger their health. Pharmacists around the nation are attempting to address this situation with something called prescription synchronization.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

Where are my instruments and sterile supplies?
Infection Control Today
As sterile processing department (SPD) professionals, the questions often heard asked by surgeons, nurses and scrub techs are: “Where are my instruments?” or “Where are my supplies?” These two questions are usually asked when patients are already in the operating room (OR) suite prepped for a lifesaving procedure, when at this point any significant delay could result in infection or death. Occasionally the answer is “I don’t know,” which escalates the situation, resulting in high levels of anxiety for all parties involved. Unfortunately for SPD providers, during a busy day the answer is true, they simply do not know.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

Clean Air Essentials

IsoTech Design is pleased to introduce its new sister company: Clean Air Essentials. The company is focused on consumables used in sterile compounding, chemo compounding, hormone compounding and environmental monitoring and on SOPs for USP 797 compliance.

Check our offers on the Essentials kit, Safety kit and sleeve kit, and ask for our latest standard operating procedures for your clean air environment.

S.O.P Cleaning & disinfecting of the C.A.I & C.A.C.I — Decontamination

IsoTech Design eNews/Infolettre

IsoTech Design Inc.
1320 Graham Blvd, #120
Montreal, QC.
H3P 3C8

To unsubscribe, click here.
Pour vous désabonner, cliquez ici.

Did someone forward this edition to you?
Subscribe here -- it's free!

Est-ce que quelqu'un vous a transféré cette infolettre?
Abonnez-vous ici -- C'est gratuit!